EcoDrugPlus

High Mobility Group Box 1a

Ensembl ID : ENSMAMG00000015140
Gene Symbol: HMGB1A
2 Cross references
511 Possible Orthologues:

High Mobility Group Box 1b

Ensembl ID : ENSMAMG00000028730
Gene Symbol: HMGB1B
3 Cross references
509 Possible Orthologues:

Histamine H2 Receptor-Like

Ensembl ID : ENSMAMG00000009396
Gene Symbol: LOC113143580
2 Cross references
182 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSMAMG00000014567
Gene Symbol: HRH1
4 Cross references
186 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSMAMG00000004464
Gene Symbol: HDAC1
3 Cross references
250 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSMAMG00000023157
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSMAMG00000026485
Gene Symbol: HDAC11
3 Cross references
201 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSMAMG00000003340
Gene Symbol: HDAC2
4 Cross references
209 Possible Orthologues:

Histone Deacetylase 4-Like

Ensembl ID : ENSMAMG00000021971
Gene Symbol: LOC113127265
2 Cross references
196 Possible Orthologues:

Histone Deacetylase 4-Like

Ensembl ID : ENSMAMG00000012917
Gene Symbol: LOC113123256
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSMAMG00000005040
Gene Symbol: HDAC5
2 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSMAMG00000011914
Gene Symbol: HDAC6
2 Cross references
180 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).